This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Best Growth Stocks to Buy for April 29th
by Zacks Equity Research
UHS, NFG and MPTI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 29, 2025
Universal Health Q1 Earnings Beat on Strong Acute Care Admissions
by Zacks Equity Research
UHS continues to witness growth in acute care facilities' patient days, while behavioral health care services witness decline.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems have been highlighted in this Industry Outlook article.
Universal Health Services (UHS) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Universal Health Services (UHS) Q1 Earnings Top Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 11.01% and 1.06%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends.
Universal Health to Report Q1 Earnings: Can it Surprise Wall Street?
by Zacks Equity Research
UHS' first-quarter earnings are likely to have benefited from growing admissions and patient days.
3 Reasons Why Universal Health Services (UHS) Is a Great Growth Stock
by Zacks Equity Research
Universal Health Services (UHS) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why Universal Health Services (UHS) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing Universal Health Services (UHS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ahead of Universal Health Services (UHS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Universal Health Services (UHS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health Services (UHS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Universal Health Services (UHS) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth Lags Q1 Earnings & Revenues, Slashes Estimates
by Zacks Equity Research
UNH continues to witness significant growth in medical costs. However, its operating cost ratio improves.
Is Universal Health Services Stock a Solid Choice Right Now?
by Zacks Equity Research
UHS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks.com featured highlights include StoneCo, BGC, Qifu Technology and Universal Health Services
by Zacks Equity Research
StoneCo, BGC, Qifu Technology and Universal Health Services have been highlighted in this Screen of The Week article.
4 Discounted PEG Stocks Based on GARP Approach to Smart Investing
by Urmimala Biswas
Here are four discounted PEG stocks, STNE, BGC, QFIN and UHS, that qualify our screening criteria.
Centene Extends SilverSummit's Presence to the Edges of Nevada
by Zacks Equity Research
CNC's subsidiary, SilverSummit, secures a five-year Nevada Medicaid contract, reinforcing its foothold in managed care in rural and frontier areas.
Wall Street Analysts Predict a 25.67% Upside in Universal Health Services (UHS): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 25.7% upside potential for Universal Health Services (UHS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's Why Universal Health Services (UHS) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day.
Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On
by Urmimala Biswas
Investors looking to maintain exposure to healthcare can invest in large-cap U.S.-based companies like UHS, BMRN and ABT.
S&P 500's Worst 4-Day Drop: 5 Stocks in the ETF That Look Cheap
by Sweta Killa
With the S&P 500 seeing the worst four-day loss, valuations have fallen, making stocks attractive.
Top Research Reports for Verizon, The Southern Co. & Blackstone
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), The Southern Company (SO) and Blackstone Inc. (BX), as well as two micro-cap stocks Utah Medical Products, Inc. (UTMD) and The Eastern Company (EML).